Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 22, 1992 - Issue 9-10
8
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Transgenic animals in the evaluation of compound efficacy and toxicity: Will they be as useful as they are novel?

&
Pages 1043-1054 | Received 05 Oct 1990, Accepted 01 Mar 1992, Published online: 22 Sep 2008

References

  • Arnold B., Goodnow C., Hengartner H., Hammerling G. The coming of transgenic mice: tolerance and immune reactivity. Immunology Today 1990; 11: 69–72
  • Babinet C., Morello D., Renard J.P. Transgenic mice. Genome 1989; 31: 938–949
  • Baribault H., Kemler R. Embryonic stem cell culture and gene targeting in transgenic mice. Molecular Biology and Medicine 1989; 6: 481–492
  • Bernstein A., Breitman M. Genetic ablation in transgenic mice. Molecular Biology and Medicine 1989; 6: 523–530
  • Bowman B.H., Yang F., Adrian G.S. Expression of human plasma protein genes in ageing transgenic mice. BioEssays 1990; 12: 317–322
  • Breitman M.L., Clapoff S., Rossant J., Tsui L., Glode M., Maxwell I.H., Bernstein A. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 1987; 238: 1563–1565
  • Breuer M., Slebos R., Verbeek S., Lohuizen M., Wientjens E., Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-I transgenic mice. Nature 1989; 340: 61–63
  • Brinster R.L., Chen H.Y., Messing A., Van Dyke T., Levine A.J., Palmiter R.D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumours. Cell 1984; 37: 367–379
  • Capecchi M.R. The new mouse genetics: altering the genome by gene targeting. Trends in Genetics 1989; 5: 70–76
  • Chisari F.V., Klopchin K., Moriyama T., Pasquinelli C., Dusford H.A., Sell S., Pinkert C.A., Brinster R.L., Palmiter R.D. Molecular pathogeneis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145–1156
  • Connelly C.S., Fahl W.E., Iannaccone P.M. The role of transgenic animals in the analysis of various biological aspects of normal and pathologic states. Experimental Cell Research 1989; 183: 257–276
  • Cordaro C.J. Transgenic mice as future tools in risk assessment. Risk Analysis 1989; 9: 157–168
  • Cuthbertson R.A., Klintworth G.K. Transgenic mice—a gold mine for further knowledge in pathology. Laboratory investigation 1988; 58: 484–502
  • Evans R.M., Swanson L., Rosenfeld M.G. Creation of transgenic animals to study development and as models of human disease. Recent Progress in Hormone Research 1985; 41: 317–337
  • Field H.J., Brown G.A. Animal models for antiviral chemotherapy. Antiviral Research 1989; 12: 165–180
  • Freeman C.S., Kimes B.W., Martin M.R., Marks C.L. An overview of cancer biology. Cancer Investigation 1989; 7: 247–265
  • Frohman M.A., Martin G.R. Cut, paste and save: new approaches to altering specific genes in mice. Cell 1989; 56: 145–147
  • Galaski H., Sullivan M., Willingham M.C., Chin K., Gottesman M.M., Pastan I., Merlino G.T. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia. Molecular and Cellular Biology 1989; 9: 4357–4363
  • Gordon J.W. Transgenic animals. Laboratory Animals 1990; 19: 27–35
  • Gordon J.W. Transgenic animals. International Review of Cytology 1989; 115: 171–229
  • Gordon J.W., Ruddle F.H. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 1981; 214: 1244–1246
  • Hanahan D. Transgenic mice as probes into complex systems. Science 1989; 246: 1265–1275
  • Hanahan D. Dissecting multistep tumorigenesis in transgenic mice. Annual Review of Genetics 1988; 22: 479–519
  • Heisterkamp N., Jenster G., Hoeve J., Zovich D., Pattengale P.K., Groffen J. Acute leukemia in bcr/abl transgenic mice. Nature 1990; 344: 251–253
  • Hogan B., Costantini F., Lacy E. Manipulating the Mouse Embryo, A Laboratory Manual. Cold Springs Harbor Laboratory, New York 1986
  • Isola L.M., Gordon J.W. Expression of a methotrexate resistant dihydrofolate reductase gene in transgenic mice. Development Genetics 1989; 10: 349–355
  • Isola L.M., Gordon J.W. Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene. Proceedings of the National Academy of Sciences 1986; 83: 9621–9625
  • Jaenisch R. Transgenic animals. Science 1988; 240: 1468–1474
  • Jenkins N.A., Copeland N.G. Transgenic mice in cancer research. Important Advances in Cancer Research. 1989; 61–77
  • Jhappan C., Stahle C., Harkins R.N., Fausto N., Smith G.H., Merlino G.T. TGF-alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61: 1137–1146
  • Lassam N., Feigenbaum L., Vogel J., Jay G. Transgenic approach for the study of pathogenesis induced by human viruses. Molecular Biology and Medicine 1989; 6: 319–331
  • Leder A., Pattengale P.K., Kuo A., Stewart T.A., Leder P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 1986; 45: 485–495
  • Mason A.J., Pitts S.L., Nikolics K., Szonyi E., Wilcox J.N., Seeburg P.H., Stewart T.A. The hypogonadal mouse: reproductive functions restored by gene therapy. Science 1986; 234: 1372–1370
  • Matsui Y., Halter S.A., Holt J.T., Hogan B. L. M., Coffey R.J. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 1990; 61: 1147–1155
  • McNeish J.D., Scott W.J., Potter S.S. Legless, a novel mutation found in PHTI-1 transgenic mice. Science 1988; 241: 837–839
  • Messing A., Chen H.Y., Palmiter R.D., Brinster R.L. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature 1985; 316: 461–463
  • Orian J.M., Tamakoshi K., Mackay I.R., Brandon M.R. New murine model for hepatocellular carcinoma: transgenic mice expressing metallothionein-ovine growth hormone fusion gene. Journal of the National Cancer Institute 1990; 82: 393–398
  • Palmiter R.D., Behringer R.R., Quaife C.J., Maxwell F., Maxwell I.H., Brinster R.L. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987; 50: 435–443
  • Palmiter R.D., Brinster R.L. Germ-line transformation of mice. Annual Review of Genetics 1986; 20: 465–499
  • Palmiter R.D., Brinster R.L. Transgenic mice. Cell 1985; 41: 343–345
  • Quaife C.J., Mathews L.S., Pinkert C.A., Hammer R.E., Brinster R.L., Palmiter R.D. Histopathology associated with elevated levels of growth hormone and insulin like growth factor I in transgenic mice. Endocrinology 1989; 124: 40–48
  • Quaife C.J., Pinkert C.A., Ornitz D.M., Palmiter R.D., Brinster R.L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 1987; 48: 1023–1034
  • Rao G.N., Huff J. Refinement of long-term toxicity and carcinogenesis studies. Fundamental and Applied Toxicology 1990; 15: 33–43
  • Sandgren E.P., Luetteke N.C., Palmiter R.D., Brinster R.L., Lee D.C. Overexpression of TGF-alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61: 1121–1135
  • Sarvetnick N., Shizuru J., Liggitt D., Martin L., McIntyre B., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990; 346: 844–847
  • Sarvetnick N., Liggitt D., Pitts S.L., Hansen S.E., Stewart T. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773–782
  • Scangos G., Bieberich C. Gene transfer into mice. Advances in Genetics 1987; 24: 285–322
  • Stewart T.A., Pattengale P.K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984; 38: 627–637
  • Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51: 503–512
  • Thompson S., Clarke A.R., Pow A.M., Hooper M.L., Melton D.W. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 1989; 56: 313–321
  • Tilghman S.M., Levine A.J. Transgenic mice: gene transfer into the germ line. Gene Transfer, R. Kucherlapati. Plenum Press, New York 1986; 189–221
  • Vogel J., Hinrichs S.H., Reynolds R.K., Luciw P.A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988; 335: 606–611
  • Westphal H. Transgenic mammals and biotechnology. FASEB Journal 1989; 3: 117–120
  • Williams D.A. Embryonic stem cells as targets for gene transfer: a new approach to molecular manipulation of the murine hematopoietic system. Bone Marrow Transplantation 1990; 5: 141–144

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.